3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
155
Leukemia, Lymphocytic, Chronic, B-Cell
43
Lymphoma, Large B-Cell, Diffuse
26
Lymphoma
25
Lymphoma, Non-Hodgkin
23
Lymphoma, Mantle-Cell
23
Lymphoma, Follicular
23
Leukemia
22
Recurrence
21
Neoplasms, Plasma Cell
19
Myelodysplastic Syndromes
12
Lymphoma, B-Cell, Marginal Zone
12
Leukemia, Myeloid, Acute
12
Waldenstrom Macroglobulinemia
8
Smoldering Multiple Myeloma
8
Hodgkin Disease
8
Prostatic Neoplasms
7
Lymphoma, B-Cell
6
Lymphoma, T-Cell
5
Lymphoma, Large-Cell, Anaplastic
5
Hematologic Diseases
5
Sezary Syndrome
4
Mycosis Fungoides
4
Lymphoma, T-Cell, Peripheral
4
Leukemia, Myelomonocytic, Chronic
4
Immunoblastic Lymphadenopathy
4
Anemia
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Polycythemia Vera
3
Lymphoma, T-Cell, Cutaneous
3
Interventions
tislelizumab
4
talazoparib
4
pembrolizumab
4
Docetaxel
4
Nivolumab
3
PM 01183
2
MLN 8237
2
Itraconazole
2
Fluorouracil
2
Cisplatin
2
Carboplatin
2
zimberelimab
1
utomilumab
1
urelumab
1
ulixertinib
1
trifluridine tipiracil drug combination
1
sitravatinib
1
sapanisertib
1
pexidartinib
1
pevonedistat
1
peposertib
1
niraparib
1
mogamulizumab
1
lenvatinib
1
ixabepilone
1
eribulin
1
durvalumab
1
dalotuzumab
1
avelumab
1
ascrinvacumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Advanced Solid Tumors
×
Lenalidomide
×
Clear all
No trials found.